Credit Suisse Maintains Neutral on Select Medical Hldgs, Raises Price Target to $32
Portfolio Pulse from richadhand@benzinga.com
Credit Suisse analyst Jonathan Yong maintains a Neutral rating on Select Medical Holdings (NYSE:SEM) and raises the price target from $29 to $32.
August 07, 2023 | 12:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Credit Suisse maintains a Neutral rating on Select Medical Holdings and raises the price target from $29 to $32.
The news is directly related to Select Medical Holdings (SEM). The raised price target indicates a positive outlook, but the maintained Neutral rating suggests that the analyst does not see significant upside potential in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100